Warning: fopen(/home/virtual/epih/journal/upload/ip_log/ip_log_2024-03.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 83 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84 The first case of the 2015 Korean Middle East Respiratory Syndrome outbreak
Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Epidemiol Health > Volume 37; 2015 > Article
MERS
Epidemiologic Investigation
The first case of the 2015 Korean Middle East Respiratory Syndrome outbreak
Yong-Shik Park1orcid, Changhwan Lee1orcid, Kyung Min Kim1orcid, Seung Woo Kim1orcid, Keon-Joo Lee1orcid, Jungmo Ahn2, Moran Ki3orcid
Epidemiol Health 2015;37:e2015049.
DOI: https://doi.org/10.4178/epih/e2015049
Published online: November 14, 2015
  • 17,123 Views
  • 186 Download
  • 22 Web of Science
  • 28 Crossref

1Division of Epidemic Intelligence Service, Korea Centers for Disease Control and Prevention, Cheongju, Korea

2Division of Public Health and Hygiene, Seoul City Hall, Seoul, Korea

3Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

Correspondence: Moran Ki  Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea  Tel: +82-31-920-2736, Fax: +82-50-4069-4908 E-mail: moranki@naver.com
• Received: September 11, 2015   • Accepted: November 14, 2015

©2015, Korean Society of Epidemiology

This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • This study reviewed problems in the prevention of outbreak and spread of Middle East Respiratory Syndrome (MERS) and aimed to provide assistance in establishing policies to prevent and manage future outbreaks of novel infectious diseases of foreign origin via in-depth epidemiological investigation of the patient who initiated the MERS outbreak in Korea, 2015. Personal and phone interviews were conducted with the patient and his guardians, and his activities in Saudi Arabia were investigated with the help of the Saudi Arabian Ministry of Health. Clinical courses and test results were confirmed from the medical records. The patient visited 4 medical facilities and contacted 742 people between May 11, 2015, at symptom onset, and May 20, at admission to the National Medical Center; 28 people were infected and diagnosed with MERS thereafter. Valuable lessons learned included: (1) epidemiological knowledge on the MERS transmission pattern and medical knowledge on its clinical course; (2) improvement of epidemiological investigative methods via closed-circuit television, global positioning system tracking, and review of Health Insurance Review and Assessment Service records; (3) problems revealed in the existing preventive techniques, including early determination of the various people contacted; (4) experiences with preventive methods used for the first time in Korea, including cohort quarantine; (5) reconsideration of the management systems for infectious disease outbreaks across the country, such as this case, at the levels of central government, local government, and the public; (6) reconsideration of hospital infectious disease management systems, culture involving patient visitation, and emergency room environments.
After landing in Korea in May of 2015, Middle East Respiratory Syndrome (MERS) resulted in a total of 186 confirmed cases and 36 deaths from May 11, when the symptoms occurred in the first patient, to July 4, when the last patient developed the symptoms [1]. A novel coronavirus confirmed for the first time in 2012 is suspected to be the cause of MERS and camels may be the host. Human-to-human transmission is known to occur after transmission from a camel to a human, but the exact route has not been sufficiently investigated [2]. The outbreak in Korea started with a patient who arrived in May 2015 from Saudi Arabia, a country that had an outbreak of a large number of MERS cases, and subsequently spread. A majority of infected patients were revealed to be cases of hospital-acquired infection [2,3].
This report is an epidemiological study of the first patient (Patient #1) who initially brought MERS into Korea in 2015. From May 20, when a diagnosis of MERS was confirmed, the Division of Epidemic Intelligence Service, Korea Centers for Disease Control and Prevention (KCDC), in cooperation with a group of civilian volunteers in epidemiology, traced the infection route and performed preventive measures for the spread of additional infections.
Through personal and phone interviews we contacted employees at business facility in Saudi Arabia who may have had contact with Patient #1 during the incubation period; we investigated the places he visited, presence or absence of MERS symptoms in the individuals he contacted, history of visiting medical facilities in the Middle East, and history of consuming camel milk or meat, among other things. The patient’s specific activities in Saudi Arabia were verified with the help of the Saudi Arabian Ministry of Health. Additionally, the timing of symptom occurrence and the initial symptoms were reevaluated by confirming the history of visiting domestic medical facilities after arrival in Korea via personal interviews with the patient and his guardians and examining his medical records. The KCDC performed a diagnostic serum antibody test for MERS for individuals whose contact with Patient #1 was confirmed by personal interviews or closed-circuit television (CCTV) reviews.
This study was conducted as an epidemiological investigation of the MERS outbreak, and thus, additional processes for review and approval by institutional review board were not required on the basis of the Life Ethics and Safety Law Enforcement Rule Item 2 (human subject studies).
Clinical course of Patient #1
Patient #1 was a 68-year-old man and had underlying diseases including asthma, hypertension, dyslipidemia, and benign prostate hypertrophy. At the time of the study, he was a current smoker. He was in the greenhouse building business with a business facility in the Middle East, specifically Bahrain, as well as at a domestic business facility in Asan, Chungnam, Korea. He visited the Middle East region about once every 2 months and stayed for approximately 3 weeks during each visit. The most recent business trip was between April 24, and May 4, 2015, for 11 days. He had business visits to Saudi Arabia (May 1 to 2) and the United Arab Emirates (April 29 to 30) with Bahrain as the base; both departure from and arrival at Korea was via Qatar. During his stay in the Middle East, he had no history of direct contact with camels, consuming camel by products such as milk or meat, or visiting the medical facilities there. In Saudi Arabia, he stayed at his business facility and the hotel in the area of Al Muzahimiyah outside of the capital, Riyadh. During his trips within the Middle East, he had no contact with animals and did not eat or drink outside the hotels where he stayed. While staying in Riyadh, he travelled with a driver, a guide, and the Bahrain business facility manager, none of whom showed the symptoms suspected of MERS. Patient #1 returned to Korea without any abnormal symptoms on May 4 via Flight OZ6888 and went to his domestic business place in Asan on May 11. On May 11, fever broke for the first time, and he visited Asan Seoul Clinic the next day (May 12). At the time of the visit, his body temperature was 37.0°C, and he complained of febrile sense and myalgia. On May 14, he visited the same place with a persistent high temperature (38.9°C) and myalgia, and on May 15, he was transferred to Pyeongtaek St. Mary’s Hospital for inpatient treatment, because respiratory symptoms such as cough and sputum had developed, his body temperature was 38.3°C, and the myalgia had worsened. After the transfer, he was in an outpatient exam room, a laboratory room, and a chest radiography room, and was put in a double-occupancy room at approximately 2 pm (Room 8104, 8th floor). Around 7:15 pm, a chest computed tomography (CT) scan was performed on the first underground floor. On the following day (May 16) at approximately 7:15 am, he visited the radiography room on the first underground floor to undergo a chest radiogram. Pneumonia in the right upper lobe was found on the chest CT scan, and infections with Haemophilus influenzae and Streptococcus pneumonia were confirmed on bacterial culture testing. From the evening of May 15, breathing difficulty and chest pain developed. Symptoms did not improve, and the patient was discharged from the hospital at 10 am on Sunday, May 17; thereafter, his wife drove him for treatment to the 365 Clinic, where he usually went for examination. The 365 Clinic referred him to a high-level medical center. He went to the Samsung Medical Center in Seoul emergency department, but returned home because a patient room was not available. On the following day (May 18) at approximately 10 am, his wife drove him again to the Samsung Medical Center in Seoul emergency department, and he was admitted. From 2 pm, he wore a facial mask. On May 19, he was reported to the KCDC as a case suspected of MERS in consideration of the clinical courses that deteriorated despite the antibiotic therapy and his history of travel to the Middle East within the previous two weeks, which was revealed during a consultation with physician. On May 20, his sputum polymerase chain reaction (PCR) test was determined positive, following which he was transferred to the National Medical Center. Patient #1 received antiviral, interferon, and antibiotic treatments, and mechanical ventilation therapy after an endotracheal intubation was performed due to worsening respiratory symptoms. On June 30, a sputum PCR test was confirmed negative for MERS virus, and it was decided that he was cured. On September 25, he was discharged after completing treatment for a sacral sore (Figure1).
Individuals who made contact with Patient #1 and preventive efforts for them
Individuals who were in direct contact with Patient #1 without appropriate personal protective equipment or who stayed with him in an enclosed space (patient room, office, etc.) were considered cases of close contact and were put under surveillance. The scope of close contact surveillance gradually expanded with the spread of the MERS outbreak, and the final count of individuals under close contact surveillance was 742: 4 employees at Patient #1’s domestic business facility in Asan, 4 medical staff members at the Asan Seoul Clinic, 672 medical staff members and patients (including Patient #1’s wife) at Pyeongtaek St. Mary’s Hospital, 39 medical staff members and patients at the 365 Clinic, and 23 medical staff members and patients at the Samsung Medical Center in Seoul. Depending on the extent of contact, they were classified into either 1) quarantine of a person or a place or 2) active observational surveillance and were closely tracked and observed (Figure 1). During surveillance, when symptoms suspected as MERS occurred, respiratory samples were collected for testing, the suspected cases were transferred to a quarantined hospital, and epidemiological investigations were conducted.
Infection transmission by Patient #1
A total of 742 people had contact with Patient #1 from May 11, when the first symptoms occurred, to May 20, when he was transferred to the National Medical Center. Of those, 28 became infected, with an infection rate of 3.8%. According to the characteristics of the contacted individuals, 4 out of 235 medical staff members (1.7%); 11 out of 206 patients (5.3%); and 13 out of 301 guardians, caregivers, and visitors (4.3%) were infected. However, trying to correlate Patient #1’s transmission capacity or epidemiological characteristics to the infection rate had limitations because with the spread of MERS, the scope of surveillance of contacted individuals gradually expanded, and the standards were not consistent across different institutions. Nonetheless, based on a study analyzing epidemiological characteristics of the MERS outbreak around Pyeongtaek St. Mary’s Hospital, the rate of infection was 3.9% overall and was 1.1% among medical staff members; 7.6% among patients; and 3.3% among guardians, caregivers, and visitors [4]. Aside from Patient #1, 3 of 28 individuals, in particular, with a confirmed diagnosis (#14, #15, and #16) individually infected more than 5 individuals whose diagnosis was additionally confirmed, and they were thus labeled as “super spreaders.” It is thought that, after contact with Patient #1, they visited different medical facilities and became epidemiologically associated with additional patients with a confirmed diagnosis [5].
The 2015 MERS outbreak in Korea started with the infection of a businessman in his 60s who often traveled to the Middle East for business. He did not show symptoms at his arrival in Korea. A week later, he started experiencing symptoms and visited medical facilities. However, it took 9 days for the MERS infection to be confirmed at the 4th medical facility he visited, and, by then, the infection transmission had already begun at the previous 3 medical facilities. Thereafter, a “MERS crisis” transpired for the first time wherein a total of 186 patients were confirmed with MERS infection; 36 deaths occurred among these patients, and 16,693 individuals were quarantined for prevention. The clinical symptoms in the first patient deteriorated because of a delay in receiving appropriate treatment, and he was assisted with mechanical ventilation. On day 42 after admission to the 4th hospital, tests for MERS virus were negative, and the patient’s condition recovered.
From the epidemiological investigation, the course of transmission to this patient in the Middle East was not clear. It can only be inferred that the first patient became infected while visiting Saudi Arabia, on the basis of a recent study showing that the MERS virus that broke out in Korea is genetically closest to the Qatar strain [5,6]. However, to uncover the specific course of transmission, we must perform an epidemiological investigation in coordination with Saudi Arabia. Various factors are considered as causes of the widespread outbreak. The first is health care workers’ lack of knowledge regarding MERS. Since June 2013, the KCDC had organized a national MERS management team in preparation of a MERS outbreak in Korea, and mock-up training had been performed to enhance the capacity to manage outbreaks of novel infectious diseases at quarantine stations and at the level of local government of cities and provinces. However, in cases such as the present case, wherein the symptoms do not manifest themselves when patients enter Korea, preventing an outbreak of a novel infectious disease by imposing quarantine is not practical. In particular, health care workers did not receive sufficient education or communication against MERS in anticipation of a case wherein a MERS-infected individual, on whom quarantine was not imposed, would go to a regional medical facility. Until the diagnosis was confirmed for Patient #1, the first 3 medical facilities that he visited were unable to suspect a MERS case. The doctor at the 3rd medical facility, who examined Patient #1 and subsequently became infected, in an interview with the media after his discharge stated that he had not even heard of MERS. The second factor communication about MERS among travelers to the Middle East was insufficient. Since 2013, when the likelihood of spread of MERS would spread within the Middle East region was indicated, the KCDC persistently promoted MERS awareness among the travelers to that region. However, Patient #1, who frequently visited the region and his family members, had no idea about MERS. Thus, when he visited the general medical facilities with respiratory symptoms, he did not mention about his travel to the Middle East, and only mentioned about his visit to Bahrain when inquired about a travel history involving the Middle East at the medical center where his diagnosis was confirmed. Therefore, MERS could not be diagnosed sooner. A third factor contributing to the rationale behind the outbreak was not kept in check earlier was that quarantine was not thoroughly imposed. After Patient #1’s diagnosis was confirmed, thorough quarantine was neither imposed on individuals who had close contact with him nor on those with casual contact (such as those who had a possibly contacted the doctors or the patients or those who were exposed to a space infected by him). Lastly, in this outbreak, most patients were infected via hospital-acquired infection because Korean medical institutions’ patient rooms and emergency rooms were very crowded, and infected patients had to visit several hospitals because of the shortcomings of the medical care delivery system, which played a critical role in the spread of MERS from hospital to hospital.
Through an investigation on the MERS outbreak within Korea, valuable lessons were learned. They include (1) accumulation of epidemiological knowledge of the pattern of MERS transmission as well as medical knowledge on its clinical courses; (2) improvement of epidemiological investigative techniques using CCTV, global positioning system tracking, and review of Health Insurance Review and Assessment Service records, among other things; (3) problems revealed in the existing preventive techniques, including the early determination of the scope of contacted people; (4) accumulation of experiences with the preventive techniques used for the first time in Korea, such as cohort quarantine; (5) reconsideration of the management systems that deal with an outbreak of infectious diseases across the country, such as in the present case, at the levels of central government, local government, and the public; and (6) reconsideration of infectious disease management system at hospitals, culture involving patient visitation, and emergency room environments.
The 2015 MERS outbreak in Korea began with an infected businessman in his 60s who visited the Middle East region. However, the spread of outbreak is attributed to insufficient preparation and management by the Ministry of Health and Welfare. To prepare for an outbreak of novel infectious diseases in future, government organizations responsible for infectious diseases need to train personnel specialized in the area, and also promote awareness among medical staff at the primary and secondary medical facilities as well as among the public. The MERS outbreak should serve as an opportunity to improve the level of managing hospital-acquired infection in Korea.

The authors have no conflicts of interest to declare for this study.

Supplementary material (Korean version) is available at http://www.e-epih.org/.
Figure 1.
Main events by date for the 1st confirmed Middle East Respiratory Syndrome (MERS) case in Korea. BPH, benign prostatic hypertrophy; CT, computed tomography; ER, emergency room; KCDC, Korea Centers for Disease Control and Prevention.
epih-37-e2015049f1.gif
  • 1. Ki M. 2015 MERS outbreak in Korea: hospital-to-hospital transmission. Epidemiol Health 2015;37:e2015033.ArticlePubMedPMC
  • 2. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet 2015;386:995-1007.ArticlePubMedPMC
  • 3. Choi JW, Kim KH, Cho YM, Kim SH. Current epidemiological situation of Middle East respiratory syndrome coronavirus clusters and implications for public health response in South Korea. J Korean Med Assoc 2015;58:487-497 (Korean).Article
  • 4. Kim KM, Ki M, Cho SI, Sung M, Hong JK, Cheong HK, et al. Epidemiologic features of the first MERS outbreak in Korea: focus on Pyeongtaek St. Mary’s Hospital. Epidemiol Health 2015;37:e2015041.ArticlePubMedPMC
  • 5. Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect 2015;6:269-278.ArticlePubMedPMC
  • 6. Durai P, Batool M, Shah M, Choi S. Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control. Exp Mol Med 2015;47:e181.ArticlePubMedPMC

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Serosurvey for Middle East respiratory syndrome coronavirus antibody in dromedary camels and human patients at a secondary care hospital, Illela, Northwest Nigeria
      Samson Polycarp Salam, Grace Sabo Nok Kia, Faleke Olufemi Oladayo, Iniobong Chukwuebuka Ikenna Ugochukwu
      Comparative Clinical Pathology.2022; 31(3): 537.     CrossRef
    • Use of surveillance technology to enhance exposure management for healthcare workers during the COVID-19 pandemic
      H.J. Ho, W.Y. Lim, B. Ang, A. Chow
      Journal of Hospital Infection.2021; 107: 101.     CrossRef
    • Assessment of general awareness among Pakistani students regarding COVID-19 outbreak
      Tanveer Hussain, Usman Shah Gilani, Samea Khan, Syed Muhammad Muslim Raza
      Children and Youth Services Review.2021; 121: 105830.     CrossRef
    • Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies
      Abdullah M Alnuqaydan, Abdulmajeed G Almutary, Arulmalar Sukamaran, Brian Tay Wei Yang, Xiao Ting Lee, Wei Xuan Lim, Yee Min Ng, Rania Ibrahim, Thiviya Darmarajan, Satheeshkumar Nanjappan, Jestin Chellian, Mayuren Candasamy, Thiagarajan Madheswaran, Ankur
      AAPS PharmSciTech.2021;[Epub]     CrossRef
    • Knowledge, awareness and practices of Pakistani professionals amid-COVID-19 outbreak
      Samea Khan, Usman Shah Gilani, Syed Muhammad Muslim Raza, Tanveer Hussain
      Scientific Reports.2021;[Epub]     CrossRef
    • Surface‒Aerosol Stability and Pathogenicity of Diverse Middle East Respiratory Syndrome Coronavirus Strains, 2012‒2018
      Neeltje van Doremalen, Michael Letko, Robert J. Fischer, Trenton Bushmaker, Jonathan Schulz, Claude K. Yinda, Stephanie N. Seifert, Nam Joong Kim, Maged G. Hemida, Ghazi Kayali, Wan Beom Park, Ranawaka A.P.M. Perera, Azaibi Tamin, Natalie J. Thornburg, Su
      Emerging Infectious Diseases.2021; 27(12): 3052.     CrossRef
    • Middle East Respiratory Syndrome Coronavirus
      Jaffar A. Al-Tawfiq, Esam I. Azhar, Ziad A. Memish, Alimuddin Zumla
      Seminars in Respiratory and Critical Care Medicine.2021; 42(06): 828.     CrossRef
    • Super-spreading events and contribution to transmission of MERS, SARS, and SARS-CoV-2 (COVID-19)
      J.A. Al-Tawfiq, A.J. Rodriguez-Morales
      Journal of Hospital Infection.2020; 105(2): 111.     CrossRef
    • Is Pakistan prepared for the COVID‐19 epidemic? A questionnaire‐based survey
      Samea Khan, Mahjabeen Khan, Khizra Maqsood, Tanveer Hussain, Noor‐ul‐Huda, Muhammad Zeeshan
      Journal of Medical Virology.2020; 92(7): 824.     CrossRef
    • Use of a Real-Time Locating System for Contact Tracing of Health Care Workers During the COVID-19 Pandemic at an Infectious Disease Center in Singapore: Validation Study
      Hanley J Ho, Zoe Xiaozhu Zhang, Zhilian Huang, Aung Hein Aung, Wei-Yen Lim, Angela Chow
      Journal of Medical Internet Research.2020; 22(5): e19437.     CrossRef
    • Molecular Evolution and Structural Mapping of N-Terminal Domain in Spike Gene of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
      Asif Naeem, Maaweya Hamed, Majed Alghoribi, Waleed Aljabr, Hadel Alsaran, Mushira Enani, Bandar Alosaimi
      Viruses.2020; 12(5): 502.     CrossRef
    • Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis
      Yewei Xie, Zaisheng Wang, Huipeng Liao, Gifty Marley, Dan Wu, Weiming Tang
      BMC Infectious Diseases.2020;[Epub]     CrossRef
    • Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature
      J.A. Al-Tawfiq, P.G. Auwaerter
      Journal of Hospital Infection.2019; 101(1): 20.     CrossRef
    • Middle East respiratory syndrome coronavirus intermittent positive cases: Implications for infection control
      Sarah H. Alfaraj, Jaffar A. Al-Tawfiq, Ziad A. Memish
      American Journal of Infection Control.2019; 47(3): 290.     CrossRef
    • Airflow analysis of Pyeongtaek St Mary's Hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea
      Seongmin Jo, Jinkwan Hong, Sang-Eun Lee, Moran Ki, Bo Youl Choi, Minki Sung
      Royal Society Open Science.2019; 6(3): 181164.     CrossRef
    • Middle East respiratory syndrome coronavirus-encoded ORF8b strongly antagonizes IFN-β promoter activation: its implication for vaccine design
      Jeong Yoon Lee, Sojung Bae, Jinjong Myoung
      Journal of Microbiology.2019; 57(9): 803.     CrossRef
    • A database of geopositioned Middle East Respiratory Syndrome Coronavirus occurrences
      Rebecca E. Ramshaw, Ian D. Letourneau, Amy Y. Hong, Julia Hon, Julia D. Morgan, Joshua C. P. Osborne, Shreya Shirude, Maria D. Van Kerkhove, Simon I. Hay, David M. Pigott
      Scientific Data.2019;[Epub]     CrossRef
    • MERS-CoV infection in South Korea and strategies for possible future outbreak: narrative review
      Chulwoo Park
      Journal of Global Health Reports.2019;[Epub]     CrossRef
    • A study of the probable transmission routes of MERS-CoV during the first hospital outbreak in the Republic of Korea
      S. Xiao, Y. Li, M. Sung, J. Wei, Z. Yang
      Indoor Air.2018; 28(1): 51.     CrossRef
    • Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea
      Myoung-don Oh, Wan Beom Park, Sang-Won Park, Pyoeng Gyun Choe, Ji Hwan Bang, Kyoung-Ho Song, Eu Suk Kim, Hong Bin Kim, Nam Joong Kim
      The Korean Journal of Internal Medicine.2018; 33(2): 233.     CrossRef
    • Asymptomatic Middle East Respiratory Syndrome coronavirus infection using a serologic survey in Korea
      Yeong-jun Song, Jeong-Sun Yang, Hee Jung Yoon, Hae-Sung Nam, Soon Young Lee, Hae-Kwan Cheong, Woo-Jung Park, Sung Han Park, Bo Youl Choi, Sung Soon Kim, Moran Ki
      Epidemiology and Health.2018; 40: e2018014.     CrossRef
    • Airflow as a Possible Transmission Route of Middle East Respiratory Syndrome at an Initial Outbreak Hospital in Korea
      Minki Sung, Seongmin Jo, Sang-Eun Lee, Moran Ki, Bo Choi, JinKwan Hong
      International Journal of Environmental Research and Public Health.2018; 15(12): 2757.     CrossRef
    • Surveys and Proposals of the Infectious Disease Home Isolation through Middle East Respiratory Syndrome (MERS) Transmission
      Song Yi An, Woong Jung, Chang Min Lee, Sung Hyuk Park, Hyun Kyung Park, Myung Chun Kim
      Korean Journal of Healthcare-Associated Infection Control and Prevention.2018; 23(2): 72.     CrossRef
    • Identified Transmission Dynamics of Middle East Respiratory Syndrome Coronavirus Infection During an Outbreak: Implications of an Overcrowded Emergency Department
      Thamer H. Alenazi, Hussain Al Arbash, Aiman El-Saed, Majid M. Alshamrani, Henry Baffoe-Bonnie, Yaseen M. Arabi, Sameera M. Al Johani, Ra’ed Hijazi, Adel Alothman, Hanan H. Balkhy
      Clinical Infectious Diseases.2017; 65(4): 675.     CrossRef
    • The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015
      Ji Yeon Lee, You-Jin Kim, Eun Hee Chung, Dae-Won Kim, Ina Jeong, Yeonjae Kim, Mi-ran Yun, Sung Soon Kim, Gayeon Kim, Joon-Sung Joh
      BMC Infectious Diseases.2017;[Epub]     CrossRef
    • Extensive Viable Middle East Respiratory Syndrome (MERS) Coronavirus Contamination in Air and Surrounding Environment in MERS Isolation Wards
      Sung-Han Kim, So Young Chang, Minki Sung, Ji Hoon Park, Hong Bin Kim, Heeyoung Lee, Jae-Phil Choi, Won Suk Choi, Ji-Young Min
      Clinical Infectious Diseases.2016; 63(3): 363.     CrossRef
    • Outbreaks of Middle East Respiratory Syndrome in Two Hospitals Initiated by a Single Patient in Daejeon, South Korea
      Sun Hee Park, Yeon-Sook Kim, Younghee Jung, Soo young Choi, Nam-Hyuk Cho, Hye Won Jeong, Jung Yeon Heo, Ji Hyun Yoon, Jacob Lee, Shinhye Cheon, Kyung Mok Sohn
      Infection & Chemotherapy.2016; 48(2): 99.     CrossRef
    • Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection
      Anurodh Shankar Agrawal, Tianlei Ying, Xinrong Tao, Tania Garron, Abdullah Algaissi, Yanping Wang, Lili Wang, Bi-Hung Peng, Shibo Jiang, Dimiter S. Dimitrov, Chien-Te K. Tseng
      Scientific Reports.2016;[Epub]     CrossRef

    Figure

    Epidemiol Health : Epidemiology and Health